Exelixis, Inc. (NASDAQ:EXEL) soared 29.87% to $6.13. The company
reported interim data early Thursday morning, from the cohort of patients with
metastatic castration-resistant prostate cancer, or CRPC, treated with XL184 in
an ongoing phase 2 adaptive randomized discontinuation trial.
The stock
went down more than 17% year-to-date.
Merck & Co., Inc. (NYSE:MRK) went up 2.06% to $35.18. So far in
the last one year of trading sessions, the stock added over 1%. The stock has a
52-week range of $30.70-$41.56.
The median
Wall Street price target on the stock is $42 and the high target is set at $48
with majority of analysts have a Buy rating on the company`s stock.
Dendreon Corporation (NASDAQ:DNDN) jumped 5.60% to $37.88. Over the
past 52-week, the stock traded within the range of $25.05-$57.67.
The company
has Price/Sales ratio of 224.40. The stock has the 50- Day Moving Average and
200-Day Moving Average prices of $37.61 and $38.37 respectively. At current
market price, the market capitalization of the company stands at $5.47 billion.
Amgen, Inc. (NASDAQ:AMGN) added 2.71% to $55.33. Over the past
52-week, the stock traded within the range of $50.26-$61.26.
The
stock has the 50- Day Moving Average and 200-Day Moving Average price of $56.08
and $54.55 respectively.
ABOUT We Pick Penny Stocks
Wepickpennystocks provide Stock Newsletter on various hot stocks of the day. To make best stock investment you need up to date stock market information. We provide alerts onpenny stock and other hot stocks of the day. Our stock news will help you gain insight into the stock trading so that you can make maximum profit.
Disclaimer:
The assembled information disseminated by wepickpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. wepickpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in wepickpennystocks.com. Please always do due diligence and consult a financial advisor.
